BofA raised the firm’s price target on American Healthcare REIT to $19 from $16 and keeps a Buy rating on the shares after the company delivered a 5c, or 18%, beat driven by better than expected core results. American Healthcare now expects normalized FFO of $1.23-$1.27 for the full-year as the midpoint was increased 3.3% and was 2.5% higher than the Street, the analyst noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $18 from $16 at JMP Securities
- American Healthcare REIT Releases Q2 Supplemental Data
- American Healthcare REIT raises FY24 NFFO view to $1.23-$1.27 from $1.18-$1.24
- American Healthcare REIT reports Q2 normalized FFO 33c, consensus 29c
- American Healthcare REIT (“AHR”) Announces Second Quarter 2024 Results; Increases Full Year 2024 Guidance